Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss

Maturitas

Volumn 58, Issue 1, 2007, Pages 59-69

  Li, J X ^a   Liu, J ^a   He, C C ^a   Yu, Z Y ^a   Du, Y ^a   Kadota, S ^b   Seto, H ^b  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bone mineral density (BMD); Bone resorption; Cimicifugae rhizoma; Osteoclast like cells; Ovariectomized (OVX) mice; Pit formation; Serum concentration; Triterpenoids

Indexed keywords

ACETYLACTEOL 3 O BETA DEXTRO XYLOSIDE; CALCITRIOL; CALCIUM 45; CALCIUM CHLORIDE; CIMICIDANOL 3 O BETA DEXTRO XYLOSIDE; CIMICIDOL 3 O BETA DEXTRO XYLOSIDE; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MARROW CELL; BONE MINERAL; CHEMICAL STRUCTURE; CIMICIFUGA; CIMICIFUGA FOETIDA; CIMICIFUGAE RHIZOMA; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; LIQUID CHROMATOGRAPHY; MOUSE; NEWBORN; NONHUMAN; ORGAN CULTURE; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; RHIZOME; SINGLE DRUG DOSE; UTERUS WEIGHT;

ANIMALS; BODY MASS INDEX; BONE RESORPTION; CIMICIFUGA; DRUGS, CHINESE HERBAL; FEMALE; MICE; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; STRUCTURE-ACTIVITY RELATIONSHIP; TREATMENT OUTCOME; TRITERPENES;

MUS;

EID: 34547935164     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.06.001     Document Type: Article

References (25)

1. Epstein S. Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clin Ther 28 (2006) 151-173
2. Edwards B.J., Brooks E., and Langman C.B. Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach. Gend Med 2 (2004) 70-85
3. Osborn B.H., Couchman G.M., Siegler I.C., and Bastian L.A. Osteoporosis risk factors: association with use of hormone replacement therapy and with worry about osteoporosis. Women's Heal Iss 9 (1999) 278-285
4. Dontas I., Halabalaki M., Moutsatsou P., et al. Protective effect of plant extract from Onobrychis ebenoides on ovariectomy-induced bone loss in rats. Maturitas 53 (2006) 234-242
5. The Commission of Pharmacopoeia of the Ministry of Public Health. The Chinese Pharmacopoeia vol. I (2005), The Chemical Industry Publishing House, Beijing, China p. 50
6. Li J.X., and Yu Z.Y. Cimicifugae rhizoma: from origins, bioactive constituents to clinical outcomes. Curr Med Chem 13 (2006) 2927-2951
7. Mahady G.B. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol 4 (2005) 177-184
8. Li J.X., Kadota S., Li H.Y., Miyahara T., and Namba T. The effect of traditional medicines on bone resorption induced by parathyroid hormone (PTH) in tissue culture: a detailed study on Cimicifugae rhizoma. J Trad Med 13 (1996) 50-58
9. Li J.X., Kadota S., Li H.Y., et al. Effects of Cimicifugae rhizoma on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomedicine 3 (1996-1997) 379-385
10. Seidlová-Wuttke D., Jarry H., Pitzel L., and Wuttke W. Effects of estradiol-17β, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats. Maturitas 51 (2005) 177-186
11. Wuttke W., Seidlová-Wuttke D., and Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44 (2003) S67-S77
12. Kadota S., Li J.X., Tanaka K., and Namba T. Constituents of Cimicifugae rhizoma. II. Isolation and structures of new cycloartenol triterpenoids and related compounds from Cimicifuga foetida L. Tetrahedron 51 (1995) 1143-1166
13. Shigeno C., Yamamoto I., Dokoh C., et al. Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia. J Clin Endocrinol Metab 61 (1985) 761-768
14. Klein-Nulend J., and Raisz L.G. Effects of two inhibitors of anion transport on bone resorption in organ culture. Endocrinology 125 (1989) 1019-1024
15. Takahashi N., Akatsu T., Udagawa N., et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123 (1988) 2600-2602
16. Notoya K., Yoshida K., Taketomi S., Yamazaki I., and Kumegawa M. Inhibitory effect of ipriflavone on osteoclast-mediated cultures of mouse unfractionated bone cells. Calcif Tissue Int 53 (1993) 206-209
17. Tamura T., Takahashi N., Akatsu T., et al. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro. J Bone Miner Res 8 (1993) 953-960
18. Bushinsky D.A., and Monk R.D. Calcium. Lancet 352 (1998) 306-311
19. Ferrari S., Bonjour J.P., and Rizzoli R. The vitamin D receptor gene and calcium metabolism. Trends Endocrinol Metab 9 (1988) 259-265
20. Jimi E., Shuto T., and Koga T. Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology 136 (1995) 808-811
21. Yoshinari N., Kawase H., and Noguchi T. The relationship between periodontal disease and osteoporosis in animals. Clin Calcium 16 (2006) 55-62
22. Iida-Klein A., Hughes C., Lu S.S., et al. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice. J Bone Miner Res 21 (2006) 274-282
23. Edwards M.W., Bain S.D., Bailey M.C., Lantry M.M., and Howard G.A. 17β-Estradiol stimulation of endosteal bone formation in the ovariectomized mouse: an animal model for the evaluation of bone-targeted estrogens. Bone 13 (1992) 29-34
24. Seidlova-Wuttke D., Hesse O., Jarry H., et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocrinol 149 (2003) 351-362
25. Koeda M., Aoki Y., Sakurai N., and Nagai M. Studies on the Chinese crude drug "shoma." IX. Three novel cyclolanostanol xylosides, cimicifugosides H-1, H-2 and H-5, from cimicifuga rhizome. Chem Pharm Bull 43 (1995) 771-776